Scientists in Moscow have completed clinical trials and are in the process of securing local regulatory approval said the Russian Foreign Minister.
Wider vaccinations would then take place in October, with doctors and teachers being vaccinated first.
The drug, which was developed by the Gamaleya Institute in Moscow and the Russian Direct Investment Fund, has completed clinical trials and will be registered with regulators in August.
Deputy Prime Minister Tatyana Golikova said that the vaccine will still need to be tested on an additional 1,600 people, but should begin production in September.
While the developers insist the drug is safe, many other countries are questioning the legitimacy of the Russians' claims.
In July, UK Foreign Secretary Dominic Raab accused Russian spies of attempting to sabotage or steal vaccine research from UK scientists.
Earlier this week, it was announced that a vaccine being developed in Oxford University was ready to enter its final phase of testing after it was determined the drug was safe and caused an immune response.
